Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Luteolin-7-rutinoside has both antifungal activities and anti-arthritic, can result in a combination therapy for the treatment of fungal arthritis due to C. albicans infection.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 約 35 days | ¥ 43,500 |
5 mg | 約 35 days | ¥ 137,000 |
10 mg | 約 35 days | ¥ 257,000 |
25 mg | 約 35 days | ¥ 537,000 |
In vitro | Luteolin-7-rutinoside demonstrates dose-dependent immunomodulatory effects in T cells and macrophages. At concentrations of 40 μg/mL, it induces T cell proliferation at a rate comparable to that seen with 20 μg/mL, indicating a potential plateau in efficacy with increased dosage. A lower dose of 10 μg/mL (referred to as lonicerin) significantly reduces T cell proliferation by approximately 47% relative to control groups treated with Luteolin-7-rutinoside (p<0.05), highlighting its suppressive capability. Additionally, Luteolin-7-rutinoside shifts the Th1-Th2 balance towards Th2-type responses and inhibits nitric oxide (NO) production from macrophages, further evidencing its immunological influence. |
分子量 | 594.52 |
分子式 | C27H30O15 |
CAS No. | 20633-84-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Luteolin-7-rutinoside 20633-84-5 Others Luteolin 7 rutinoside Luteolin7rutinoside Inhibitor inhibitor inhibit